Document Detail


Treatment of hypertension with angiotensin converting enzyme inhibitors.
MedLine Citation:
PMID:  6097208     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Angiotensin converting enzyme inhibitors are effective therapy in hypertension. They are particularly useful in severe drug resistant or accelerated hypertension, in renal hypertension and in hypertensive heart failure. Although their exact mode of action has not been determined it is a consequence of the inhibition of angiotensin converting enzyme. They offer distinct advantages over conventional drugs in the treatment of high blood pressure particularly as they have no central or autonomic side effects and as a consequence the patients feel well. There is no postural effect on blood pressure and patients retain their normal cardiovascular reflex mechanisms and sexual function. They are particularly useful when combined with diuretics or salt restriction as not only do they have additive hypotensive effects but angiotensin converting enzyme inhibitors prevent the secondary hyperaldosteronism and hypokalemia associated with diuretic administration. Lastly, unlike many other forms of treatment for hypertension, renal blood flow and renal function tend to be maintained with converting enzyme inhibitors. Their overall role in the management of hypertension has yet to be determined, and the ultimate incidence of adverse effects after prolonged therapy is not yet known. They are however, an exciting new development in the treatment of hypertension.
Authors:
C I Johnston
Related Documents :
20402578 - Moderate pressure is essential for massage therapy effects.
25060208 - Pulmonary hypertension and hashimoto's thyroiditis: does a relationship exist?
11551378 - What is the optimal strategy to intensify blood pressure control and prevent progressio...
431188 - Hypertensive emergencies.
3083078 - Inadvertent positive end-expiratory pressure in mechanically ventilated newborn infants...
8445308 - Knot to be condemned.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Australian and New Zealand journal of medicine     Volume:  14     ISSN:  0004-8291     ISO Abbreviation:  Aust N Z J Med     Publication Date:  1984 Aug 
Date Detail:
Created Date:  1985-01-28     Completed Date:  1985-01-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1264322     Medline TA:  Aust N Z J Med     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  509-13     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors*
Antihypertensive Agents / adverse effects,  metabolism,  pharmacology,  therapeutic use*
Captopril / adverse effects,  metabolism,  pharmacology,  therapeutic use*
Dipeptides / adverse effects,  metabolism,  pharmacology,  therapeutic use*
Drug Interactions
Enalapril
Humans
Hypertension / drug therapy*
Hypertension, Malignant / drug therapy
Hypertension, Renal / drug therapy
Kinetics
Proline / analogs & derivatives*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 0/Dipeptides; 147-85-3/Proline; 62571-86-2/Captopril; 75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunization with Nematospiroides dubius adult worms plus pertussigen has different consequences in ...
Next Document:  Nitrophenylphosphatase activity in the kidney sac nephrocytes of Helix aspersa.